The Selection and Use of Essential Medicines - WHO Technical Report Series, No. 920: Selected WHO Publications of Related Interest

The Selection and Use of Essential Medicines - WHO Technical Report Series, No. 920
(2003; 137 pages)

Índice de contenido

1. Introduction
2. Open session
3. Update on current activities
	3.1 Dissemination of the previous report of the Expert Committee (including the 12th Model List)
	3.2 The twenty-fifth anniversary of the WHO Model List of Essential Medicines
	3.3 The WHO model formulary
	3.4 Review of the New Emergency Health Kit
	3.5 Review of essential medicines for reproductive health
	3.6 Report of an ad hoc Advisory Committee on priority vaccines
	3.7 The WHO Essential Medicines Library
	3.8 Promoting rational use of essential medicines
		3.8.1 Update on activities to contain antimicrobial resistance
		3.8.2 Guidelines for drugs and therapeutic committees
		3.8.3 WHO database on rational drug use studies
4. Changes made in revising the Model List
	4.1 Applications for additions
		4.1.1 Amodiaquine
		4.1.2 Azithromycin
		4.1.3 Ibuprofen (paediatric formulation)
		4.1.4 Insulin semilente
		4.1.5 Miconazole nitrate buccal tablets
		4.1.6 Misoprostol
		4.1.7 Valaciclovir
	4.2 Applications for deletions
		4.2.1 Ethinylestradiol + levonorgestrel tablets (50µg + 250µg, pack of four)
		4.2.2 Nonoxynol
	4.3 Applications for addition of information
		4.3.1 Anti-leprosy medicines
	4.4 Other changes
		4.4.1 Oral rehydration salts
		4.4.2 Streptokinase
5. Reviews of sections of the Model List
	5.1 "Fast-track" procedure for deleting items from the Model List
	5.2 Review of core versus complementary listing of medicines
	5.3 Review of the use of the square box symbol (including a review of the corticosteroids)
	5.4 Review of the antihypertensive medicines
6. Priorities for future reviews
7. Recommendations
	7.1 Additions, deletions and other changes to the Model List
	7.2 Core versus complementary listing of medicines
	7.3 Use of the square box symbol (including review of the corticosteroids
	7.4 Review of the antihypertensive medicines
	7.5 Future priorities
References
Annex 1 The 13th WHO Model List of Essential Medicines
Annex 2 The Anatomical Therapeutic Chemical (ATC) classification system¹
Alphabetical list of essential medicines (with ATC classification code numbers)
Selected WHO Publications of Related Interest

Selected WHO Publications of Related Interest

The international pharmacopoeia, third edition.

Volume 1: general methods of analysis. 1979 (223 pages)

Volume 2: quality specifications. 1981 (342 pages)

Volume 3: quality specifications. 1988 (407 pages)

Volume 4: test, methods, and general requirements: quality specifications for pharmaceutical substances, excipients, and dosage forms. 1994 (358 pages)

Volume 5: tests and general requirements for dosage forms: quality specifications for pharmaceutical substances and dosage forms. 2003 (389 pages)

Basic tests for drugs: pharmaceutical substances, medicinal plant materials and dosage forms.

1998 (94 pages)

Basic tests for pharmaceutical dosage forms.

1991 (134 pages)

Quality assurance of pharmaceuticals: a compendium of guidelines and related materials.

Volume 1: 1997 (244 pages)

Volume 2, Updated edition: good manufacturing practices and inspection. 2004 (236 pages)

Quality control methods for medicinal plant materials.

1998 (123 pages)

WHO Expert Committee on Specifications for Pharmaceutical Preparations.

Thirty-eight report.
WHO Technical Report Series, No. 917, 2004 (125 pages)

International nonproprietary names (INN) for pharmaceutical substances. Cumulative list no. 10.

2002 (available as CD-ROM only)

The selection and use of essential medicines.

Report of the WHO Expert Committee (including the 12th Model List of Essential Medicines)
WHO Technical Report Series, No. 914, 2003 (126 pages)

WHO Expert Committee on Biological Standardization.

Fiftieth report.
WHO Technical Report Series, No. 904, 2002 (113 pages)

WHO model formulary.

2004 (528 pages)

Further information on these and other WHO publications can be obtained from Marketing and Dissemination, World Health Organization, 1211 Geneva 27, Switzerland.